MOS
BIO icon

MGO One Seven’s Bio-Rad Laboratories Class A BIO Stock Holding History

MGO One Seven’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-420
Closed -$216K – 498
2020
Q3 		$216K Buy
+420
New +$213K 0.05% 404
2019
Q1 		– Sell
-669
Closed -$155K – 537
2018
Q4 		$155K Sell
669
-145
-18% -$38.9K 0.07% 336
2018
Q3 		$254K Buy
+814
New +$253K 0.12% 251
2018
Q1 		$101K Hold
405
– – 0.05% 438
2017
Q4 		$97K Buy
+405
New +$98.1K 0.04% 444

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

MGO One Seven's BIO Position: Q4 2020 in Review

MGO One Seven sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2020, closing a stake of 420 shares — an estimated $216K sold.

MGO One Seven first reported a position in BIO in Q4 2017 and held it in 5 quarters. The position peaked at $254K in Q3 2018. 491 funds tracked by Wall St. Rank hold BIO as of Q4 2020.

  • MGO One Seven reported no remaining Bio-Rad Laboratories Class A position as of Q4 2020 after selling out during the quarter.
  • MGO One Seven sold 420 Bio-Rad Laboratories Class A shares in Q4 2020, an estimated $216K.
  • MGO One Seven first reported a position in Bio-Rad Laboratories Class A in Q4 2017 and held it in 5 quarters.
  • MGO One Seven's Bio-Rad Laboratories Class A position peaked at $254K in Q3 2018.
  • 491 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2020.

Based on MGO One Seven's 13F filing for Q4 2020, filed 22 Jan 2021.